Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.72 |
| ▸ | PTPN22 | Q9Y2R2 | 2/20 | 0.68 |
| ▸ | APEX1 | P27695 | 1/20 | 0.67 |
| ▸ | MAP3K5 | Q99683 | 3/20 | 0.66 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.61 |
| ▸ | EIF4E | P06730 | 1/20 | 0.60 |
| ▸ | EIF4G1 | Q04637 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3905933 | 0.91 | MAPT (0.77) | MAPTPTPN22APEX1MAP3K5EIF4E | |
| SCHEMBL3904248 | 0.91 | MAPT (0.77) | MAPTPTPN22APEX1MAP3K5EIF4E | |
| SCHEMBL7859580 | 0.91 | MAPT (0.77) | MAPTPTPN22APEX1MAP3K5EIF4E | |
| SCHEMBL7860584 | 0.88 | MAPT (0.73) | MAPTPTPN22APEX1MAP3K5HIF1AN | |
| SCHEMBL12676815 | 0.85 | MAPT (0.70) | MAPTPTPN22APEX1MAP3K5HIF1AN | |
| SCHEMBL3899060 | 0.85 | MAPT (0.70) | MAPTPTPN22APEX1MAP3K5HIF1AN | |
| SCHEMBL3899067 | 0.85 | MAPT (0.70) | MAPTPTPN22APEX1MAP3K5HIF1AN | |
| SCHEMBL3892576 | 0.85 | HIF1AN (0.81) | MAPTPTPN22APEX1MAP3K5HIF1AN | |
| SCHEMBL13056328 | 0.85 | HIF1AN (0.81) | MAPTPTPN22APEX1MAP3K5HIF1AN | |
| SCHEMBL3892582 | 0.85 | HIF1AN (0.81) | MAPTPTPN22APEX1MAP3K5HIF1AN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7947717-B2 | Inhibitors of lethal factor protease | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2011-05-24 | — | — | US | disclosed |
| US-20100016292-A1 | INHIBITORS OF LETHAL FACTOR PROTEASE | THE BURNHAM INSTITUTE (US) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016292-A1 | INHIBITORS OF LETHAL FACTOR PROTEASE | APAF1, F11, SERPINB1 | MAPT 2957/4885PTPN22 2193/4885APEX1 2617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.